Suppr超能文献

[非酶糖基化。生物学。病理学]

[Non-enzymatic glycosylation. Biology. Pathology].

作者信息

Lestradet H

出版信息

Ann Pediatr (Paris). 1991 Apr;38(4):229-34.

PMID:2069357
Abstract

Enzymatic glycosylation of proteins should be clearly distinguished from non-enzymatic glycosylation or glycation. Both processes occur in normal subjects but are enhanced in patients with hyperglycemia. Increased enzymatic glycation in patients with diabetes mellitus is responsible for thickening and weakening of capillary membranes, resulting in microangiopathy with microaneurisms, bleeding, and circulatory exclusion. Non-enzymatic glycosylation (glycation) affects all the proteins in the body and, if intense enough, may modify the activity or effectiveness of some molecules (apolipoproteins, membrane receptors, or even insulin itself). In everyday practice, glycated serum albumin and, above all, glycated hemoglobin serve as markers to evaluate the effectiveness of therapy in patients with diabetes mellitus.

摘要

蛋白质的酶促糖基化应与非酶促糖基化或糖基化终产物形成明确区分。这两个过程在正常个体中都会发生,但在高血糖患者中会增强。糖尿病患者体内酶促糖基化增加会导致毛细血管膜增厚和变薄,从而引发伴有微动脉瘤、出血和循环障碍的微血管病变。非酶促糖基化(糖基化终产物)会影响体内所有蛋白质,若程度足够严重,可能会改变某些分子(载脂蛋白、膜受体,甚至胰岛素本身)的活性或效能。在日常临床实践中,糖化血清白蛋白,尤其是糖化血红蛋白可作为评估糖尿病患者治疗效果的指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验